INVESTORS & MEDIA

Corporate Governance

Date Name Title Filing Type Shares Traded Price Total Held
May 29, 2020
Sanofi
Ten Percent Owner
Trans History: 555
 Ten Percent Owner Form 4 Open market or private sale of non-derivative or derivative security 20,421,899 $509.85 --
Nov 08, 2005
NOVARTIS PHARMA AG
Ten Percent Owner
Trans History: 1
 Ten Percent Owner Form 4 Open market or private sale of non-derivative or derivative security 7,527,050 $11.06 --
May 29, 2020
Sanofi
Ten Percent Owner
Trans History: 555
 Ten Percent Owner Form 4 Open market or private sale of non-derivative or derivative security 2,399,552 $509.85 400,000
Oct 13, 2010
SANOFI-AVENTIS
Ten Percent Owner
Trans History: 555
 Ten Percent Owner Form 4 Open market or private purchase of non-derivative or derivative security 1,017,401 $28.00 15,816,953
Dec 31, 2020
SCHLEIFER LEONARD S
Director, President & CEO
Trans History: 398
 Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 620,270 -- 620,270
Dec 31, 2020
YANCOPOULOS GEORGE
Director, President and Chief Scientific
Trans History: 598
 Director, President and Chief Scientific Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 620,270 -- 620,270
Feb 13, 2014
YANCOPOULOS GEORGE
Director, President Regeneron Laboratori
Trans History: 598
 Director, President Regeneron Laboratori Form 4 Bona fide gift 568,343 -- 500,000
Feb 13, 2014
YANCOPOULOS GEORGE
Director, President Regeneron Laboratori
Trans History: 598
 Director, President Regeneron Laboratori Form 4 Bona fide gift 568,343 -- 568,343
Jun 13, 2019
YANCOPOULOS GEORGE
Director, President and CSO
Trans History: 598
 Director, President and CSO Form 4 Bona fide gift 500,000 -- 500,000
Jun 13, 2019
YANCOPOULOS GEORGE
Director, President and CSO
Trans History: 598
 Director, President and CSO Form 4 Bona fide gift 500,000 -- 253,316

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Share This Page